by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles This segment takes a deeper dive into toxicity management—focusing not just on what to monitor, but how institutions are putting these protocols into action in real-world clinical settings. Read More
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles The FDA approved the MenQuadfi vaccine for young children, enhancing protection against invasive meningococcal disease and its severe complications. Read More
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Alice H. Lichtenstein, DSc, emphasizes the importance of whole-food dietary patterns over macronutrient percentages for improving lipid profiles and cardiovascular health. Read More
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Pre-treatment DPYD genotyping significantly reduces hospitalizations and costs for patients with cancer, enhancing safety and efficiency in oncology care. Read More
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Corrine Stahura, PharmD, and Sophia Gilardone, PharmD, BCOP, discuss how patient- and treatment-related factors influence the risk of severe toxicity with antibody-drug conjugates (ADCs) in non–small cell lung cancer (NSCLC). Read...
